May 11, 2026 04:34PM
Dec 31, 2025 12:55PM
Oct 14, 2025 06:22AM
Oct 14, 2025 06:21AM
Oct 8, 2025 06:33AM
Sep 19, 2025 06:08AM
Jul 17, 2025 06:07AM Johnson & Johnson (JNJ) PT Raised to $185 at Goldman Sachs
Jul 10, 2025 06:02AM
May 14, 2025 04:40PM
Apr 8, 2025 05:07AM
Feb 15, 2025 10:00PM
Jan 22, 2025 11:11AM
Sep 16, 2024 05:03AM
May 30, 2024 07:25AM Goldman Sachs Reinstates Johnson & Johnson (JNJ) at Neutral
May 15, 2024 05:49AM
May 14, 2024 07:13PM
May 13, 2024 06:53AM
May 13, 2024 06:46AM
May 13, 2024 06:46AM
May 8, 2024 04:30PM
Apr 14, 2024 02:00PM Johnson & Johnson (JNJ) stock: 1Q24 earnings preview
Oct 12, 2023 09:04AM
Aug 23, 2023 06:21AM
Aug 23, 2023 06:20AM
Aug 21, 2023 06:20AM
Aug 16, 2023 06:52PM
Jul 24, 2023 06:26AM
Jul 24, 2023 06:18AM Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
Jul 19, 2023 08:29AM
Jul 17, 2023 08:49AM
May 10, 2023 04:30PM
May 8, 2023 04:35PM
May 8, 2023 04:33PM
May 4, 2023 05:28AM
May 3, 2023 07:22PM Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
Apr 24, 2023 05:10PM
Apr 24, 2023 04:27PM
Apr 19, 2023 05:37AM
Apr 17, 2023 08:24AM
Dec 16, 2022 07:11AM
Nov 1, 2022 06:30AM
Nov 1, 2022 06:30AM Johnson & Johnson to Acquire Abiomed
Oct 18, 2022 08:02AM
Jul 19, 2022 08:59AM
May 12, 2022 04:30PM
Apr 20, 2022 07:44AM
Apr 19, 2022 05:54AM
Jan 26, 2022 07:36AM
Dec 17, 2021 06:44AM UPDATE: Goldman Sachs Starts Johnson & Johnson (JNJ) at Neutral
Nov 12, 2021 06:31AM

185,326 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All